Pharmacokinetics and pharmacodynamics of pantoprazole sodium at different doses in healthy volunteers

Xiaoyu LI; Shenglan SHANG; Lirong XIONG; Fengjun SUN; Rongfeng XIANG; Xuewen QIU; Mingjie YU; Ruoxi WANG; Yongchuan CHEN

doi:10.16016/j.1000-5404.201802146

您当前的位置：

首页 >

文章列表页 >

Pharmacokinetics and pharmacodynamics of pantoprazole sodium at different doses in healthy volunteers

更新时间：2026-01-09

- Pharmacokinetics and pharmacodynamics of pantoprazole sodium at different doses in healthy volunteers
- Journal of Third Military Medical University Vol. 40, Issue 17, Pages: 1613-1618(2018)
- 作者机构：
- 作者简介：
- 基金信息：
  
  the Science and Technology Innovation Special Project of Social Undertakings and People's Livelihood Security of Chongqing(CSTC2017shmsA130043)
- DOI：10.16016/j.1000-5404.201802146
  CLC：
- Received：27 February 2018，
  
  Published：15 September 2018
- 稿件说明：
移动端阅览
Xiaoyu LI, Shenglan SHANG, Lirong XIONG, et al. Pharmacokinetics and pharmacodynamics of pantoprazole sodium at different doses in healthy volunteers[J]. Journal of Third Military Medical University, 2018, 40(17): 1613-1618.
DOI：

Xiaoyu LI, Shenglan SHANG, Lirong XIONG, et al. Pharmacokinetics and pharmacodynamics of pantoprazole sodium at different doses in healthy volunteers[J]. Journal of Third Military Medical University, 2018, 40(17): 1613-1618. DOI： 10.16016/j.1000-5404.201802146.

摘要

Abstract

Objective

To investigate the pharmacokinetic and pharmacodynamic properties of pantoprazole sodium at different doses of injection and explore its safety in healthy Chinese volunteers.

Methods

A single center

randomized

open

and parallel controlled trial was designed for this study. Twenty healthy subjects were screened by a stratified randomization method for men and women to receive multiple doses of pantoprazole sodium of 40 and 80 mg (twice daily for 5 consecutive days)

respectively. The intragastric pH value was monitored 24 h after administration.S-(-)-pantoprazole sodium concentration was determined by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). The data were analyzed by WinNonlin 6.4 software and SAS software respectively.

Results

After the first intravenous infusion of pantoprazole sodium

the main pharmacokinetic parameters of S-(-)-pantoprazole after 40 and 80 mg groups were as follows: C

max

were 2.37±0.61 and 4.56±0.89 μg/mL; AUC

(0-t)

4.96±3.26 and 10.16±3.16 μg·h/mL; AUC

(0-∞)

5.17±3.68 and 10.34±3.35 μg·h/mL; t

1/2

1.67±0.76 and 1.75±0.57 h; and T

max

0.50±0.01 and 0.53±0.08 h. After 5 days'

continuous administration

the main pharmacokinetic parameters were as follows: C

max

were 2.30±0.62 and 4.50±0.71 μg/mL; AUC

(0-t)

5.02±3.85 and 10.75±3.82 μg·h/mL; AUC

(0-∞)

5.26±4.35 and 10.98±4.10 μg/mL·h; C

min

0.03±0.08 and 0.05±0.07 μg/mL; t

1/2

1.72±0.78 and 1.80±0.64 h; and T

max

0.52±0.04 and 0.50±0.00 h. After the first day of treatment

the both groups had (38.6±20.9)% and (46.9±16.5)%

respectively of time with gastric juice pH

and (25.5±20.6)% and (32.7±7.9)% respectively with pH

6. In 5 d after the administration

the time percentage of gastric juice pH

4 was (69.6±15.4)% and (80.2±16.6)%

respectively

and it of pH

6 was (48.3±13.7)% and (49.7±15.7)%

respectively.

Conclusion

The pantoprazole sodium for injection is in accordance with the linear pharmacokinetic characteristics in healthy volunteers. Compared with the pharmacodynamic parameters of 2 doses

the inhibitory effect of 80 mg dose group is better than that of 40 mg dose group

and the higher dose is safer. It is recommended of 80 mg q12 h in clinical practice.

关键词

Keywords

references

隋淼王晓波袭荣刚泮托拉唑钠在健康人体内的相对生物利用度及生物等效性研究中国医药导报 2013 10 9 9 11, 14 10.3969/j.issn.1673-7210.2013.09.004 隋淼, 王晓波, 袭荣刚, 等.泮托拉唑钠在健康人体内的相对生物利用度及生物等效性研究[J].中国医药导报, 2013, 10(9): 9-11, 14.

SUI M WANG X B XI R G Pharmacokinetics and relative bioavailability and bioequialence of Pantoprazole Sodium Enteric-Coated Tablet in healthy volunteer China Med Herald 2013 10 9 9 11, 14 10.3969/j.issn.1673-7210.2013.09.004 SUI M, WANG X B, XI R G, et al . Pharmacokinetics and relative bioavailability and bioequialence of Pantoprazole Sodium Enteric-Coated Tablet in healthy volunteer[J ] .China Med Herald, 2013, 10(9): 9-11, 14.

孙培红鲁云兰质子泵抑制剂的药理作用及临床应用中国医院用药评价与分析 2003 3 3 180 184 10.3969/j.issn.1672-2124.2003.03.017 孙培红, 鲁云兰.质子泵抑制剂的药理作用及临床应用[J].中国医院用药评价与分析, 2003, 3(3): 180-184.DOI:10.3969/j.issn.1672-2124.2003.03.017.

SUN P H LU Y L Pharmacological action and clinical application of proton pump inhibitors Eval Analy Drug-Use Hosp China 2003 3 3 180 184 10.3969/j.issn.1672-2124.2003.03.017 SUN P H, LU Y L. Pharmacological action and clinical application of proton pump inhibitors[J]. Eval Analy Drug-Use Hosp China, 2003, 3(3):180-184.DOI:10.3969/j.issn.1672-2124.2003.03.017.

陈尚君刘冰熔泮托拉唑对CYP2C19强代谢型消化性溃疡药动学的影响研究临床合理用药 2012 5 7C 13 14 http://d.old.wanfangdata.com.cn/Periodical/lchlyyzz201221007 陈尚君, 刘冰熔.泮托拉唑对CYP2C19强代谢型消化性溃疡药动学的影响研究[J].临床合理用药, 2012, 5(7C): 13-14.

CHEN S J LIU B R The effects of pantoprazole on pharmacokinetic of CYP2C19 EMs peptic ulcer Clin Rational Drug Use 2012 5 7C 13 14 http://d.old.wanfangdata.com.cn/Periodical/lchlyyzz201221007 CHEN S J, LIU B R.The effects of pantoprazole on pharmacokinetic of CYP2C19 EMs peptic ulcer[J].Clin Rational Drug Use, 2012, 5(7C): 13-14.

谭玉娟马玉奎方超左旋泮托拉唑钠对幽门结扎大鼠胃溃疡模型的治疗作用中国比较医学杂志 2015 25 8 54 57 10.3969/j.issn.1671.7856.2015.008.011 谭玉娟, 马玉奎, 方超.左旋泮托拉唑钠对幽门结扎大鼠胃溃疡模型的治疗作用[J].中国比较医学杂志, 2015, 25(8):54-57.DOI:10.3969.j.issn.1671.7856.2015.008.011.

TAN Y J MA Y K FANG C Protective effects of left-handed pantoprazole sodium on the rat model of gastric ulcer generated by pyloric ligation Chin J Comparative Med 2015 25 8 54 57 10.3969/j.issn.1671.7856.2015.008.011 TAN Y J, MA Y K, FANG C. Protective effects of left-handed pantoprazole sodium on the rat model of gastric ulcer generated by pyloric ligation[J].Chin J Comparative Med, 2015, 25(8):54-57.DOI:10.3969.j.issn.1671.7856.2015.008.011.

ZHAN X B GUO X R LI Z S Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study Med Sci Monit 2012 18 2 CR125 CR130 http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_3560577 ZHAN X B, GUO X R, LI Z S, et al . Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover study[J ] . Med Sci Monit, 2012, 18(2): CR125-CR130.

高成璐张新峰沈晓红 LC-MS/MS法测定人血浆中泮托拉唑浓度与人体药动学研究中国临床药学杂志 2015 24 4 227 231 10.19577/j.cnki.issn10074406.2015.04.004 高成璐, 张新峰, 沈晓红, 等. LC-MS/MS法测定人血浆中泮托拉唑浓度与人体药动学研究[J].中国临床药学杂志, 2015, 24(4):227-231.DOI:10.19577/j.cnki.issn10074406.2015.04.004.

GAO C L ZHANG X F SHEN X H LC-MS/MS determination of pantoprazole in human plasma and clinical pharmacokinetic study Chin J Clin Pharm 2015 24 4 227 231 10.19577/j.cnki.issn10074406.2015.04.004 GAO C L, ZHANG X F, SHEN X H, et al . LC-MS/MS determination of pantoprazole in human plasma and clinical pharmacokinetic study[J ] .Chin J Clin Pharm, 2015, 24(4):227-231. DOI:10.19577/j.cnki.issn10074406.2015.04.004.

刘朋黄建权陈頔液质联用测定人血浆中泮托拉唑的浓度中国药学杂志 2013 48 8 633 635 10.11669/cpj.2013.08.013 刘朋, 黄建权, 陈頔, 等.液质联用测定人血浆中泮托拉唑的浓度[J].中国药学杂志, 2013, 48(8): 633-635.DOI:10.11669/cpj.2013.08.013.

LIU P HUANG J Q CHEN D Determination of pantoprazole in human plasma by LC-MS/MS Chin Pharm J 2013 48 8 633 635 10.11669/cpj.2013.08.013 LIU P, HUANG J Q, CHEN D, et al . Determination of pantoprazole in human plasma by LC-MS/MS[J ] .Chin Pharm J, 2013, 48(8):633-635. DOI:10.11669/cpj.2013.08.013.

华雯妍张全英周文佳液相色谱-质谱联用法测定人血浆泮托拉唑药物浓度及应用中国药学杂志 2014 49 2 143 146 10.11669/cpj.2014.02.015 华雯妍, 张全英, 周文佳, 等.液相色谱-质谱联用法测定人血浆泮托拉唑药物浓度及应用[J].中国药学杂志, 2014, 49(2): 143-146.DOI:10.11669/cpj.2014.02.015.

HUA W Y ZHANG Q Y ZHOU W J LC-MS/MS determination of pantoprazole in human plasma and its application Chin Pharm J 2014 49 2 143 146 10.11669/cpj.2014.02.015 HUA W Y, ZHANG Q Y, ZHOU W J, et al . LC-MS/MS determination of pantoprazole in human plasma and its application[J ] .Chin Pharm J, 2014, 49(2): 143-146. DOI:10.11669/cpj.2014.02.015.

JIAO H LI Y SUN L A chiral LC-MS/MS method for the enantioselective determination of R-(+)- and S-(-)-pantoprazole in human plasma and its application to a pharmacokinetic study of S-(-)-pantoprazole sodium injection Biomed Chromatogr 2017 31 10 e3980 10.1002/bmc.3980 JIAO H, LI Y, SUN L, et al . A chiral LC-MS/MS method for the enantioselective determination of R-(+)- and S-(-)-pantoprazole in human plasma and its application to a pharmacokinetic study of S-(-)-pantoprazole sodium injection[J ] . Biomed Chromatogr, 2017, 31(10):e3980. DOI:10.1002/bmc.3980.

TÄUBEL J J SHARMA V K CHIU Y L A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastricpH Aliment Pharmacol Ther 2001 15 11 1807 1817 10.1046/j.1365-2036.2001.01098.x TÄUBEL J J, SHARMA V K, CHIU Y L, et al . A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastricpH[J ] . Aliment Pharmacol Ther, 2001, 15(11): 1807-1817. DOI:10.1046/j.1365-2036.2001.01098.x.

VAN RENSBURG C J CHEER S Pantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleeding Clin Med Insights Gastroenterol 2012 5 51 60 10.4137/CGast.S9893 VAN RENSBURG C J, CHEER S. Pantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleeding[J]. Clin Med Insights Gastroenterol, 2012, 5: 51-60. DOI:10.4137/CGast.S9893.

SHIN J M KIM N Pharmacokinetics and pharmacodynamics of the proton pump inhibitors J Neurogastroenterol Motil 2013 19 1 25 35 10.5056/jnm.2013.19.1.25 SHIN J M, KIM N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors[J]. J Neurogastroenterol Motil, 2013, 19(1): 25-35. DOI:10.5056/jnm.2013.19.1.25.

XIAO Z S GOLDSTEIN J A XIE H G Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele J Pharmacol Exp Ther 1997 281 1 604 609 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=JJ0210084899 XIAO Z S, GOLDSTEIN J A, XIE H G, et al . Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele[J ] . J Pharmacol Exp Ther, 1997, 281(1): 604-609.

OATES N S SHAH R R IDLE J R Influence of oxidation polymorphism on phenformin kinetics and dynamics Clin Pharmacol Ther 1983 34 6 827 834 10.1038/clpt.1983.257 OATES N S, SHAH R R, IDLE J R, et al . Influence of oxidation polymorphism on phenformin kinetics and dynamics[J ] . Clin Pharmacol Ther, 1983, 34(6): 827-834. DOI:10.1038/clpt.1983.257.

VAN RENSBURG C J HARTMANN M THORPE A Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer Am J Gastroenterol 2003 98 12 2635 2641 10.1111/j.1572-0241.2003.08723.x VAN RENSBURG C J, HARTM ANN M, THORPE A, et al . Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer[J ] . Am J Gastroenterol, 2003, 98(12): 2635-2641. DOI:10.1111/j.1572-0241.2003.08723.x.

翟丽华王启仪沙卫红不同剂量泮托拉唑对消化性溃疡并出血高危患者胃内pH的影响新医学 2015 46 4 254 258 10.3969/g.issn.0253-9802.2015.04.011 翟丽华, 王启仪, 沙卫红, 等.不同剂量泮托拉唑对消化性溃疡并出血高危患者胃内pH的影响[J].新医学, 2015, 46(4):254-258.DOI:10.3969/g.issn.0253-9802.2015.04.011.

ZHAI L H WANG Q Y SHA W H Effect of different doses of pantoprazole on intra-gastric pH in patients with a high risk of peptic ulcer bleeding New Med 2015 46 4 254 258 10.3969/g.issn.0253-9802.2015.04.011 ZHAI L H, WANG Q Y, SHA W H, et al . Effect of different doses of pantoprazole on intra-gastric pH in patients with a high risk of peptic ulcer bleeding[J ] .New Med, 2015, 46(4):254-258. DOI:10.3969/g.issn.0253-9802.2015.04.011.

魏向利淡春英不同剂量泮托拉唑治疗急性非静脉曲张性上消化道出血效果观察临床医学研究与实践 2016 1 22 86 87 http://d.old.wanfangdata.com.cn/Periodical/lcyxyjysj201622049 魏向利, 淡春英.不同剂量泮托拉唑治疗急性非静脉曲张性上消化道出血效果观察[J].临床医学研究与实践, 2016, 1(22): 86-87.

WEI X L DAN C Y Clinical effect of different dose of pantoprazole in the treatment of acute nonvariceal upper gastrointestinal bleeding Clin Res Pract 2016 1 22 86 87 http://d.old.wanfangdata.com.cn/Periodical/lcyxyjysj201622049 WEI X L, DAN C Y. Clinical effect of different dose of pantoprazole in the treatment of acute nonvariceal upper gastrointestinal bleeding[J].Clin Res Pract, 2016, 1(22): 86-87.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmacokinetics and pharmacodynamics of injectable dex-rabrazole for healthy people

Single-dose and multiple-dose pharmacokinetics of levofloxacin in Chinese healthy subjects

Pharmacokinetic study of ranolazine in Chinese healthy volunteers

Determination of ginsenoside Rg3 in rat plasma using high-performance liquid chromatography-tandem mass spectrometry

Efficacy and safety evaluation of docetaxel liposome inarabbit model bearing orthotopically transplanted VX2 tumor

Related Author

Lin CHENG

Qin DAI

Xiaochuan LI

Shu ZHANG

Xiaoqing YUAN

郁继诚

张菁

曹国英

Related Institution

Department of Pharmacy, First Affiliated Hospital, Army Medical University (Third Military Medical University)

Department of Pharmacy, Handan Branch of No. 980 Hospital of PLA

Department of Pharmacy, the First Affiliated Hospital of Chongqing Medical University

Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Chongqing Medical University

Department of Pharmaceutical Chemistry and Biological Materials, College of Pharmacy, Chongqing Medical University

⁰